Adage Capital, Point72 Raise Stakes In These Pharmaceutical Companies

Steve Cohen is among the most successful hedge fund managers in the industry, having a real-time net worth of $12 billion according to Forbes. Point72 Asset Management is the family office of the hedge fund billionaire, and has a public equity portfolio valued at $14.34 billion, according to its latest 13F filing. The hedge fund has invested strongly in the consumer discretionary and energy sectors, with its top ten stock holdings accounting for 14.50% of its portfolio. EOG Resources Inc (NYSE:EOG) and Amazon.com, Inc. (NASDAQ:AMZN) are its top stock holdings.

Uniqure NV (NASDAQ:QURE) is a pharmaceutical company that specializes in gene therapy for orphan diseases. Glybera is the first product of the company, used in the treatment of lipoprotein lipase deficiency. It has several other pipeline products including gene treatments for hearing loss, Sanfilippo B, hemophilia, Parkinson’s disease, and porphyria. Uniqure NV (NASDAQ:QURE) announced its second quarter financial results on August 27, reporting revenues of $1.62 million and net losses of $18.89 million. Among the hedge funds that we track at Insider Monkey, 17 had aggregate holdings of $87.31 million in the company at the end of the second quarter. Sectoral Asset Management and Tourbillon Capital Partners were its top shareholders, having 649,880 shares and 540,000 shares in their portfolios, respectively.

Disclosure: None